Approaches to modernize the combination drug development paradigm

Recent advances in genomic sequencing and omics-based capabilities are uncovering tremendous therapeutic opportunities and rapidly transforming the field of cancer medicine. Molecularly targeted agents aim to exploit key tumor-specific vulnerabilities such as oncogenic or non-oncogenic addiction and...

Descripción completa

Detalles Bibliográficos
Autores principales: Day, Daphne, Siu, Lillian L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084460/
https://www.ncbi.nlm.nih.gov/pubmed/27793177
http://dx.doi.org/10.1186/s13073-016-0369-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084460/
https://www.ncbi.nlm.nih.gov/pubmed/27793177
http://dx.doi.org/10.1186/s13073-016-0369-x

Ejemplares similares